References:
- El-Ayadi M, Ansari M, Sturm D,
et al. High-grade glioma in very young children: a rare and particular
patient population. Oncotarget . 2017;8(38):64564-64578
- Gielen GH, Gessi M, Buttarelli FR, et al. Genetic Analysis of Diffuse
High-Grade Astrocytomas in Infancy Defines a Novel Molecular
Entity. Brain Pathol . 2015;25(4):409-417
- Guerreiro Stucklin AS, Ryall S, Fukuoka K, et al. Alterations in
ALK/ROS1/NTRK/MET drive a group of infantile hemispheric
gliomas. Nat Commun . 2019;10(1):4343
- Wu G, Diaz AK, Paugh BS, et al. The genomic landscape of diffuse
intrinsic pontine glioma and pediatric non-brainstem high-grade
glioma. Nat Genet . 2014;46(5):444-450
- Laetsch TW, DuBois SG, Mascarenhas L, et al. Larotrectinib for
paediatric solid tumours harbouring NTRK gene fusions: phase 1 results
from a multicentre, open-label, phase 1/2 study [published
correction appears in Lancet Oncol. 2018
May;19(5):e229]. Lancet Oncol . 2018;19(5):705-714
- Hong DS, DuBois SG, Kummar S, et al. Larotrectinib in patients with
TRK fusion-positive solid tumours: a pooled analysis of three phase
1/2 clinical trials. Lancet Oncol . 2020;21(4):531-540
- Ziegler DS, Wong M, Mayoh C, et al. Brief Report: Potent clinical and
radiological response to larotrectinib in TRK fusion-driven high-grade
glioma. Br J Cancer . 2018;119(6):693-696